Multidrug Combinations against SARS-CoV-2 Using GS-441524 or Ivermectin with Molnupiravir and/or Nirmatrelvir in Reconstituted Human Nasal Airway Epithelia

• Egile Nagusiak: Denise Siegrist (Egilea), Hulda R. Jonsdottir (Egilea), Mendy Bouveret (Egilea), Bernadett Boda (Egilea), Samuel Constant (Egilea), Olivier B. Engler (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2024-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

<b>Background.</b> The emergence, global spread, and persistence of SARS-CoV-2 resulted in an unprecedented need for effective antiviral drugs. Throughout the pandemic, various drug development and treatment strategies were adopted, including repurposing of antivirals designed for other...